VIROPHARMA INCORPORATED, as the Company and BUYERS, as defined herein CONVERTIBLE NOTES REGISTRATION RIGHTS AGREEMENT Dated as of October 18, 2004Convertible Notes Registration Rights Agreement • October 19th, 2004 • Viropharma Inc • Pharmaceutical preparations • New York
THIS CONVERTIBLE NOTES REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is entered into as of October 18, 2004, by and among VIROPHARMA INCORPORATED, a Delaware corporation (the “Company”), and the buyers listed on the Schedule of Buyers attached hereto as Exhibit A (each, a “Buyer” and, collectively, the “Buyers”).
VIROPHARMA INCORPORATED, as the Company and BUYERS, as defined herein SECURITIES PURCHASE AGREEMENT Dated as of October 18, 2004 10% Senior Secured Bridge Notes due 2005 and Warrants to Purchase Common StockSecurities Purchase Agreement • October 19th, 2004 • Viropharma Inc • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of October 18, 2004, by and among ViroPharma Incorporated, a Delaware corporation (the “Company”), and the Buyers listed on the Schedule of Buyers attached hereto as Exhibit A (individually, a “Buyer” and, collectively, the “Buyers”).
VIROPHARMA INCORPORATED, as the Company and BUYERS, as defined herein INITIAL REGISTRATION RIGHTS AGREEMENT Dated as of October 18, 2004Initial Registration Rights Agreement • October 19th, 2004 • Viropharma Inc • Pharmaceutical preparations • New York
THIS INITIAL REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is entered into as of October 18, 2004, by and among VIROPHARMA INCORPORATED, a Delaware corporation (the “Company”), and the buyers listed on the Schedule of Buyers attached hereto as Exhibit A (each, a “Buyer” and, collectively, the “Buyers”).
PLEDGE AND COLLATERAL AGREEMENT dated October 18, 2004 among VIROPHARMA INCORPORATED, as Pledgor, as Trustee, and as Collateral Agent and as Securities IntermediaryPledge and Collateral Agreement • October 19th, 2004 • Viropharma Inc • Pharmaceutical preparations • New York
This PLEDGE AND COLLATERAL AGREEMENT (this “Pledge Agreement”) is made and entered into as of October 18, 2004 (the “Closing Date”) by VIROPHARMA INCORPORATED, a Delaware corporation (the “Pledgor”), U.S. BANK NATIONAL ASSOCIATION, as trustee (in such capacity, the “Trustee”) under the Indenture referred to below, and U.S. BANK NATIONAL ASSOCIATION, as (a) collateral agent (in such capacity, the “Collateral Agent”) for the Secured Parties (as hereinafter defined) and (b) securities intermediary (in such capacity, the “Securities Intermediary”) with respect to the Collateral Account (as hereinafter defined).
